A Mischo
Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse
Gössi F, Schardt J, Bargetzi M, Berthold D, Hess U, Stenner F, Mischo A, Panagiotis S, Zweifel M, Spahn M, Pabst T. Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse. Bone Marrow Transplant 2016; 52:334-336.
Nov 28, 2016Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse
Nov 28, 2016Bone Marrow Transplant 2016; 52:334-336
Gössi F, Schardt J, Bargetzi M, Berthold D, Hess Urs, Stenner F, Mischo A, Panagiotis S, Zweifel M, Spahn M, Pabst T
Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma
Schuberth P, Renner C, Fox B, Bifulco C, Tinguely M, Thiel M, Held G, Mischo A, Haile S, Haley D, Gautschi F, Wadle A, Jensen S, Jakka G, Petrausch U. Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma. Gene Ther 2012
Jun 28, 2012Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma
Jun 28, 2012Gene Ther 2012
Schuberth P C, Renner C, Fox B A, Bifulco C B, Tinguely M, Thiel M, Held G, Mischo A, Haile Sarah, Haley D, Gautschi F, Wadle A, Jensen S M, Jakka G, Petrausch U
Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy
Petrausch U, Renner C, Mischo A, Hany T, Knuth A, Soyka J, Veit-Haibach P, Haile S, Samaras P, Schäefer N. Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy. Ann Oncol 2010; 21:1694-8.
Feb 5, 2010Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy
Feb 5, 2010Ann Oncol 2010; 21:1694-8
Petrausch U, Renner C, Mischo A, Hany T F, Knuth A, Soyka J D, Veit-Haibach P, Haile Sarah, Samaras P, Schäefer N G